Navigation Links
An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - New data from an investigational study released at the American Diabetes Association (ADA) 67th Annual Scientific Sessions showed that initial combination therapy with Januvia(TM) (sitagliptin) and metformin demonstrated significant improvement in markers of beta cell function in patients with type 2 diabetes. Pancreatic islet beta cell function determines the ability of the body to produce insulin, a hormone which plays a central role in the regulation of blood sugar levels. New data from a separate pharmacologic study reported today in an oral presentation revealed that, when used in combination in healthy adults, the different mechanisms of action of JANUVIA and metformin had a complementary effect on glucagon-like peptide-1 (GLP-1) levels, another hormone that is an important regulator of blood sugar levels. This aspect of the mechanism of action of metformin used in combination with JANUVIA was previously unknown. GLP-1 acts, in part, by enhancing pancreatic beta cell insulin production and secretion.

JANUVIA is a selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances a natural body system, called the incretin system, which helps to regulate glucose by affecting the beta cells and alpha cells in the pancreas. JANUVIA is the first and only DPP-4 inhibitor to be approved and marketed in the United States for patients with type 2 diabetes. JANUVIA is indicated, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus. JANUVIA is also indicated to improve glycemic control, in combination with metformin or a thiazolidinedione (TZD), in patients with type 2 diabetes when the single agent alone plus diet and exercise do not provide adequate glycemic control. JANUVIA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these se
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:9/15/2014)... Research and Markets has announced the addition of ... 9th Edition" report to their offering. ... market and all of its segments, providing customers with a ... Business Planning. This is the ninth edition of ... and early 2014. New entrants, new technologies have entered the ...
(Date:9/15/2014)... , Sept. 15, 2014  Decision Resources Group finds ... to expand, increasing pressure to control expenditures will result ... emphasize that although type 2 diabetes drugs will generally ... likely to enforce additional restrictions on expensive agents. Surveyed ... , Germany , Italy ...
(Date:9/15/2014)... 15, 2014 Following ... to exit or end market development and ... Tropane Alkaloid APIs (active pharmaceutical ingredients) - ... Homatropine Hydrobromide, Digoxin and Cimetropium Bromide - ... commitment to maintain production and regulatory (Drug ...
Breaking Medicine Technology:The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 2Interviewed Payers in the EU5 Anticipate Increasing Prescribing Constraints for Premium-Priced Type 2 Diabetes Agents 3Alchem International Commits to Tropane Alkaloid APIs and Extends Production and Regulatory Support to Resolve Supply Gap 2
... Reportlinker.com announces that a new market ... Infectious Immunology Reagents, ... Analysis, Competitive Landscape and Market Forecasts to ... Infectious Immunology Reagents, Instruments ...
... Reportlinker.com announces that a new market research report is ... - Global Drug Forecasts and Treatment Analysis to 2020 ... Bladder Cancer - Global Drug Forecasts ... Summary GlobalData, the ...
Cached Medicine Technology:Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 2Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 3Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 4Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 5Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 6Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 7Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 8Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 9Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 10Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 11Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 12Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 13Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 14Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 15Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 16Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 17Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 18Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 19Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 20Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 21Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 22Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 23
(Date:9/15/2014)... September 16, 2014 Career Step, ... corporate training, is pleased to announce that Panacea ... and PCS comprehensive skill assessments and the ICD-10-CM ... University and Panacea’s consulting division. , “We are ... of ICD-10 to our clients,” said Suzanne Lappen, ...
(Date:9/15/2014)... Web-based training targeted at college-aged men is an ... on U.S. campuses, according to a researcher in the ... The RealConsent program reduced sexually violent behavior and increased ... a sexual assault, said Dr. Laura Salazar, associate professor ... in the paper, “A Web-Based Sexual Violence Bystander Intervention ...
(Date:9/15/2014)... 15, 2014 Imaging can be a ... who might benefit from aggressive intervention, according to a ... , The study looked at people with asymptomatic ... vessels supplying blood to the head due to atherosclerosis, ... cause of up to 20 percent of ischemic strokes, ...
(Date:9/15/2014)... a cost-effective way to identify people at risk for ... a new modeling study published online in the journal ... people with asymptomatic carotid artery stenosis, a narrowing of ... due to atherosclerosis, or plaque buildup. Carotid artery stenosis ... of ischemic strokes, which result from an obstruction within ...
(Date:9/15/2014)... CA (PRWEB) September 15, 2014 DISCcert, ... its next two-day DISC Certification Workshop for ... professionals will meet locally to take part in the ... with effective tools and activities that can be immediately ... designed to teach trainers to educate employees and staff ...
Breaking Medicine News(10 mins):Health News:Panacea Healthcare Solutions to Resell Career Step’s ICD-10-CM and PCS Assessments and Case Studies 2Health News:Panacea Healthcare Solutions to Resell Career Step’s ICD-10-CM and PCS Assessments and Case Studies 3Health News:Study: Web Based Training Can Reduce Campus Rape 2Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 2Health News:RSNA: Imaging Identifies Asymptomatic People at Risk for Stroke 3Health News:Imaging identifies asymptomatic people at risk for stroke 2Health News:Imaging identifies asymptomatic people at risk for stroke 3Health News:DISCcert Announces Two-day DISC Certification Workshop Oct 16 and 17 2Health News:DISCcert Announces Two-day DISC Certification Workshop Oct 16 and 17 3
... Public Health; Progress Needed,in Other Key Areas, SPRINGFIELD, ... three very low grades in tobacco control policies from,the ... which,highlighted significant progress in smoke free air and outlined ... cigarette tax and youth,access. Illinois received the following grades:, ...
... Funding will allow the Washington Association of Sheriffs and ... through a 30-Day DNA testing program, OLYMPIA, Wash., ... President on December 26, 2007 included a $961,000 earmark,for ... to,continue the important DNA Stranger Rape Program., "Without ...
... strong financial and clinical foundation, in preparation for release of technology ... ... for diabetes, EMERYVILLE, Calif., Jan. 10 Tethys Bioscience ... to,release Tethys Diabetes PreDxTM, a multi-biomarker technology that provides,a more complete ...
... causes neurodegenerative disorder called spinal muscular atrophy , , THURSDAY, ... wrong while she was still pregnant with her second child. ... one side of her body, leaving her stomach flat. ... born. "He had a very weak cry, very little muscle ...
... in the Jan. 10 edition of the New England ... treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive ... childbearing years. There currently are no treatments for ... may be going misdiagnosed or undiagnosed. , Researchers ...
... found in human hair shows promise for promoting the regeneration ... option when nerves are cut or crushed from trauma. ... Forest University School of Medicine reported that in animal studies ... and improve nerve function compared to current treatment options. , ...
Cached Medicine News:Health News:American Lung Association Report Gives Illinois Mixed Grades 2Health News:American Lung Association Report Gives Illinois Mixed Grades 3Health News:Congressional Budget Includes Earmark to Keep Washington's Sexual Assault DNA Program Moving Forward 2Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 2Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 3Health News:Years-Long Search Unlocks Deadly Genetic Disease 2Health News:Years-Long Search Unlocks Deadly Genetic Disease 3Health News:Years-Long Search Unlocks Deadly Genetic Disease 4Health News:New research demonstrates potential diagnosis, treatment benefits 2Health News:New research demonstrates potential diagnosis, treatment benefits 3Health News:New research demonstrates potential diagnosis, treatment benefits 4Health News:Protein in human hair shows promise for regenerating nerves 2Health News:Protein in human hair shows promise for regenerating nerves 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: